Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: Compared in heart-failure prognostication

Texas Heart Institute Journal

Volumn 39, Issue 1, 2012, Pages 30-35

  Ordu, Serkan ^a,b   Ozhan, Hakan ^a   Alemdar, Recai ^a   Aydin, Mesut ^a   Caglar, Onur ^a   Yuksel, Hatice ^a   Kandis, Hayati ^a  

^a DUZCE UNIVERSITY   (Turkey)

^b Department of Cardiology   (Turkey)

Author keywords

Biological markers blood; Brain blood; CA 125 antigen blood; Diagnostic tests; Health status indicators; Heart failure physiopathology; Natriuretic peptide; Predictive value of tests; Routine utilization; Sensitivity and specificity

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CA 125 ANTIGEN; CREATINE KINASE MB; HEMOGLOBIN;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INTERMETHOD COMPARISON; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AGED; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TURKEY;

EID: 84865836027     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Stewart S, MacIntyre K, Capewell S, McMurray JJ. Heart failure and the aging population: an increasing burden in the 21st century? Heart 2003;89(1):49-53.
2. Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007;116(5):e99-109.
3. Kouris NT, Zacharos ID, Kontogianni DD, Goranitou GS, Sifaki MD, Grassos HE, et al. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Eur J Heart Fail 2005;7(2):199-203.
4. D'Aloia A, Faggiano P, Aurigemma G, Bontempi L, Ruggeri G, Metra M, et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol 2003; 41(10):1805-11.
5. Nagele H, Bahlo M, Klapdor R, Rodiger W. Fluctuations of tumor markers in heart failure patients pre and post heart transplantation. Anticancer Res 1999;19(4A):2531-4.
6. Balion C, Santaguida PL, Hill S, Worster A, McQueen M, Oremus M, et al. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Evid Rep Technol Assess (Full Rep) 2006;(142):1-147.
7. Nagele H, Bahlo M, Klapdor R, Rodiger W. Tumor marker determination after orthotopic heart transplantation. J Heart Lung Transplant 1999;18(10):957-62.
8. Nagele H, Bahlo M, Klapdor R, Schaeperkoetter D, Rodiger W. CA 125 and its relation to cardiac function. Am Heart J 1999;137(6):1044-9.
9. Nunez J, Nunez E, Consuegra L, Sanchis J, Bodi V, Martinez-Brotons A, et al. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart 2007; 93(6):716-21.
10. Chen YX, Wang XQ, Fang CF, Wang JF, Tang LJ. Value of BNP and tumour marker CA125 in patients with heart failure. Acta Cardiol 2008;63(4):501-6.
11. Epiney M, Bertossa C, Weil A, Campana A, Bischof P. CA125 production by the peritoneum: in-vitro and in-vivo studies. Hum Reprod 2000;15(6):1261-5.
12. Seo T, Ikeda Y, Onaka H, Hayashi T, Kawaguchi K, Kotake C, et al. Usefulness of serum CA125 measurement for monitoring pericardial effusion. Jpn Circ J 1993;57(6):489-94.
13. Sevinc A, Buyukberber S, Sari R, Kiroglu Y, Turk HM, Ates M. Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids. Gynecol Oncol 2000;77(2):254-7.
14. Turk HM, Pekdemir H, Buyukberber S, Sevinc A, Camci C, Kocabas R, et al. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumour Biol 2003;24(4):172-5.
15. Kubonishi I, Bandobashi K, Murata N, Daibata M, Ido E, Sonobe H, et al. High serum levels of CA125 and interleukin-6 in a patient with Ki-1 lymphoma. Br J Haematol 1997; 98(2):450-2.
16. MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol 1997;79(8):1128-11.
17. XE-universal currency converter [Internet]. Available from: http://www.xe.com/ucc/ [cited 2012 Jan 13].